SuperworthSpectral AI price to book ratio MDAI
Market value divided by the book value of the company's net assets, since 2021.
- Today, Oct 23, 2026
- n/m
- not a meaningful number
- Last meaningful
- 23.8×
- Mar 2024
- 5-year median
- 61.0×
- 5-year range
- 20.9× to 62.4×
- Peer median
- 2.6×
Spectral AI's price to book ratio is not a meaningful number today: shareholders' equity was zero, negative or not reported, so price to book does not exist.
It was last meaningful in Mar 2024, at 23.8×.
On the days it had one over the last 5 years, its median was 61.0×, from 20.9× in Feb 2024 to 62.4× in Nov 2021.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2024 | 23.8× | 20.9× | 34.3× |
| 2023 | 27.5× | 27.5× | 37.4× |
| 2022 | n/m a value too high to mean anything | ||
| 2021 | 62.4× | 60.9× | 62.4× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Spectral AI's size, closest first, today.
| Company | Price to book ratio |
|---|---|
| MDAISpectral AI | n/m |
| NEPHNephros | 3.2× |
| APTAlpha Pro Tech | 0.9× |
| KEQUKewaunee Scientific | 1.3× |
| PDEXPro DEX | 4.2× |
| UTMDUtah Medical Products | 1.9× |
| INFUInfuSystem | 4.7× |
| EMBCEmbecta | n/m |
| Peer median | 2.6× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on Spectral AI
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.